MIT Technology Review’s latest Roundtables event dissected the scientific and commercial frontier of cognitive immortality, revealing a $190 million federal program quietly doubling as a life-extension moonshot.
Senior biomedicine editor Antonio Regalado and science editor Mary Beth Griggs examined projects ranging from head transplants and brain freezing to AI-driven “mind clones.”
The U.S. government program, officially aimed at developing replacement brain tissue for stroke treatment, functions as “a fig leaf for the actual ambition” of living forever, Regalado said. He described the initiative after “following the money, the science, and the philosophy” and returning “part skeptical, part awestruck.”
On the digital front, large language models are enabling the creation of AI copies that mimic a person’s behavior. “This digital avatar might not be good enough for you, but what if it’s good enough for me?” Regalado said, framing the question of whether a simulation can satisfy survivors even if it fails the original subject.

Not every approach leans on software. The startup Nectome proposes preserving brains within 12 minutes of medically assisted death. “If you’re selling a hot product, this is not it,” Regalado said of the pitch.
The discussions also surfaced philosophical uncertainty about what, exactly, is being preserved. “I’m not even sure that I have a very good claim to be myself,” Regalado said. A more pragmatic upside was offered for existence as a preserved brain: “You can surf the internet. I do that pretty much 12 hours a day, anyway.”
MIT Technology Review, founded in 1899 as The Technology Review, claims to be the oldest technology magazine in the world. Wholly owned by the Massachusetts Institute of Technology, it was re-launched in 1998 and again reshaped in 2005 under editor-in-chief Jason Pontin to focus on the commercialization of new technology for a global audience of executives, researchers, and policymakers. In 2011, it won an Utne Reader Independent Press Award for Best Science/Technology Coverage.
The full conversation is available on demand to subscribers of MIT Technology Review. Whether any of these strategies can deliver on the promise of cognitive immortality remains an open question.